/

Renasant Bio

Develops oral small-molecule therapies for genetic kidney disorders.

BiotechnologyPharmaceuticals renasantbio.com ↗

Company facts

Founded: 2022
Employees: 30
Headquarters: United States
Type: Private
Funding: Seed · $54.5M · 2025